Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

What you need to know about the coronavirus right now

05/14/2021 | 01:28am EDT

May 14 (Reuters) - Here's what you need to know about the coronavirus right now:

Indian variant spreads around globe

India's tally of coronavirus infections climbed past 24 million on Friday, amid reports flowed that the highly transmissible variant first detected there was spreading around the globe.

The Indian B.1.617 variant has been found in eight nations in the Americas, including Canada and the United States, said Jairo Mendez, an infectious diseases expert with the World Health Organization.

Britain will adapt its vaccine rollout to protect people more quickly in areas where the Indian variant has emerged, the vaccine minister said on Friday.

Nearly half the 150 passengers booked on Australia's first repatriation flight from India were barred from boarding on Friday, after they or their close contacts tested positive.

Lab leak theory cannot be ruled out

The origin of the novel coronavirus is still unclear and the theory that it was caused by a laboratory leak needs to be taken seriously until there is a rigorous data-led investigation that proves it wrong, a group of leading scientists said.

"More investigation is still needed to determine the origin of the pandemic," said the 18 scientists, including Ravindra Gupta, a clinical microbiologist at the University of Cambridge, and Jesse Bloom, who studies the evolution of viruses at the Fred Hutchinson Cancer Research Center.

"Theories of accidental release from a lab and zoonotic spillover both remain viable," the scientists said in a letter to the journal Science.

Singapore brings in strictest curbs since lockdown

Singapore announced on Friday the strictest curbs on social gatherings and public activities since easing a lockdown last year, amid a rise in locally acquired infections and with new coronavirus clusters forming in recent weeks.

The new measures announced by the health ministry, which will be in force from Sunday to mid June, include limiting social gatherings to two people and ceasing dining in at restaurants.

"This is clearly a setback in our fight against COVID-19," said Lawrence Wong, the minister for education who co-chairs Singapore's coronavirus taskforce.

Japan adds 3 prefectures to state of emergency

Japan said on Friday it would declare a state of emergency in three more prefectures hit hard by the pandemic, in a surprise move reflecting growing concerns about the virus's spread.

The latest state of emergency declarations would come as Japan grapples with a surge of a more infectious strain of COVID-19 just 10 weeks before the Tokyo Olympics are due to start.

Hokkaido, Okayama and Hiroshima will join Tokyo, Osaka and four other prefectures on Sunday under a state of emergency until May 31.

Taiwan community transmissions spread

Taiwan reported a record rise in domestic COVID-19 cases on Friday with 29 new infections, as community transmissions in part of central Taipei spread and the government called for people to be tested.

While Taiwan has reported just 1,291 cases, mostly imported from abroad, a recent small rise in domestic infections has spooked a population long used to the island's relative safety.

Health Minister Chen Shih-chung told a news conference that of the 29 new domestic infections many were connected with an outbreak in Taipei's Wanhua district, an often gritty area of old temples, trendy shops and hostess bars. (Compiled by Linda Noakes; Editing by Giles Elgood)


© Reuters 2021
All news about ASTRAZENECA PLC
04:03aASTRAZENECA  : Family doctors say they can answer vaccine questions, after Trude..
AQ
01:37aASTRAZENECA  : India hopes COVID-19 cases stabilising even as daily deaths stay ..
RE
05/14Taiwan tightens curbs after surge in domestic COVID-19 cases
RE
05/14ASTRAZENECA  : Experts call on Canada to use COVAX doses of AstraZeneca or give ..
AQ
05/14ASTRAZENECA  : You Want It When?! EU Sues AstraZeneca Over Vaccine Delivery Dela..
AQ
05/14ASTRAZENECA  : Angola Calls for Equity in Vaccine Distribution
AQ
05/14ASTRAZENECA  : Egypt receives second shipment of 1.77 million COVID-19 vaccines ..
AQ
05/14ASTRAZENECA  : Egypt receives second shipment of 1.77 million COVID-19 vaccines ..
AQ
05/14ASTRAZENECA  : Italy audit court rejects public funding for ReiThera COVID-19 va..
RE
05/14ASTRAZENECA  : Italy audit court rejects public funding for ReiThera COVID-19 va..
RE
More news
Financials (USD)
Sales 2021 31 426 M - -
Net income 2021 4 488 M - -
Net Debt 2021 10 883 M - -
P/E ratio 2021 32,7x
Yield 2021 2,57%
Capitalization 145 B 145 B -
EV / Sales 2021 4,98x
EV / Sales 2022 4,36x
Nbr of Employees 76 100
Free-Float 95,7%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Average target price 130,45 $
Last Close Price 110,83 $
Spread / Highest target 49,7%
Spread / Average Target 17,7%
Spread / Lowest Target -13,2%
EPS Revisions
Managers and Directors
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC7.37%145 472
JOHNSON & JOHNSON8.16%448 257
ROCHE HOLDING AG-1.80%290 657
PFIZER, INC.8.94%224 020
ABBVIE INC.8.66%205 641
NOVARTIS AG-3.78%200 099